scispace - formally typeset
C

Christopher Etherton-Beer

Researcher at University of Western Australia

Publications -  141
Citations -  2855

Christopher Etherton-Beer is an academic researcher from University of Western Australia. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 22, co-authored 110 publications receiving 2136 citations. Previous affiliations of Christopher Etherton-Beer include Harry Perkins Institute of Medical Research & Government of Western Australia.

Papers
More filters
Journal ArticleDOI

The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis

TL;DR: In this article, a review aimed to determine whether or not deprescribing is a safe, effective and feasible intervention to modify mortality and health outcomes in older adults, and the authors found that although non-randomized data suggested that deprecribing reduces mortality, depresncribing was not shown to alter mortality in randomized studies.

Cost effectiveness of patient education for the prevention of falls in hospital : economic evaluation from a randomized controlled trial

TL;DR: In this paper, a multimedia patient education program provided with trained health professional follow-up was shown to reduce falls among cognitively intact hospital patients, with a 52% probability the complete program was both more effective and less costly (from the health service perspective) than providing usual care alone.
Journal ArticleDOI

Cost effectiveness of patient education for the prevention of falls in hospital: economic evaluation from a randomized controlled trial

TL;DR: If the proportion of cognitively intact patients falling on a ward under usual care conditions is 4% or greater, then provision of the complete program in addition to usual care will likely both prevent falls and reduce costs for a health service.
Journal ArticleDOI

Deprescribing in Frail Older People: A Randomised Controlled Trial

TL;DR: Deprescribing reduced the number of regular medicines consumed by frail older people living in residential care with no significant adverse effects on survival or other clinical outcomes.